5-((3,5-diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl)oxy)benzene-1,3-dicarbonitrile,
lersivirine,
UK 453,061,
UK 453061,
UK-453,061,
UK-453061,
UK453,061,
UK453061,
Lersivirine,
473921-12-9,
UK-453061,
UNII-R3ZGC15A9A,
3-CYANO-5-[[3,5-DIETHYL-1-(2-HYDROXYETHYL)-1H-PYRAZOL-4-YL]OXY]BENZONITRILE,
R3ZGC15A9A,
UK-453,061,
UK 453061,
5-((3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl)oxy)isophthalonitrile,
5-[3,5-diethyl-1-(2-hydroxyethyl)pyrazol-4-yl]oxybenzene-1,3-dicarbonitrile,
5-((3,5-Diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl)oxy)benzene-1,3-dicarbonitrile,
5-{[3,5-Diethyl-1-(2-Hydroxyethyl)-1h-Pyrazol-4-Yl]oxy}benzene-1,3-Dicarbonitrile,
Lersivirine [USAN:INN],
2won,
ZZE,
Lersivirine (USAN/INN),
LersivirineUK 453061,
UK 453,061,
Lersivirine(UK-453061),
Lersivirine?UK 453061?,
SCHEMBL508446,
CHEMBL571987,
DTXSID0057881,
EX-A165,
BCP08443,
ZINC1912267,
3776AH,
MFCD16619314,
AKOS030526818,
CS-1191,
DB11649,
SB17095,
1,3-Benzenedicarbonitrile, 5-((3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl)oxy)-,
NCGC00378968-01,
AN-28223,
DA-42388,
HY-14267,
AB0165609,
FT-0745075,
D09634,
W-5646,
921C129,
5-{3,5-diethyl-1-(2hydroxyethyl)-1H-pyrazol-4-yl]isophthalonitrile,
Lersivirine [USAN],
C17H18N4O2,
A3548,
A12667,
5-(3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yloxy)benzene-1,3-dinitrile,